Determinants of atypical antipsychotic use among antipsychotic users in community-dwelling elderly, 1996-2004

Current Medical Research and Opinion

Volumn 24, Issue 3, 2008, Pages 709-716

  Jano, Elda ^a   Johnson, Michael ^a   Chen, Hua ^a   Aparasu, Rajender R ^a  

^a UNIVERSITY OF HOUSTON   (United States)

Author keywords

Antipsychotic; Atypical; Dementia; Elderly

Indexed keywords

ARIPIPRAZOLE; CLOZAPINE; NEUROLEPTIC AGENT; OLANZAPINE; QUETIAPINE; RISPERIDONE; ZIPRASIDONE;

ADULT; AGED; ANXIETY; ARTICLE; DEMENTIA; DRUG USE; FEMALE; HEALTH CARE; HEALTH SURVEY; HISPANIC; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RESEARCH; MENTAL HEALTH; MULTIPLE REGRESSION; PERCEPTION; PRESCRIPTION; SCHIZOPHRENIA; STATISTICAL ANALYSIS; TREATMENT OUTCOME; UNITED STATES;

AGE FACTORS; AGED; AGED, 80 AND OVER; ANTIPSYCHOTIC AGENTS; ANXIETY; BENZODIAZEPINES; CROSS-SECTIONAL STUDIES; DEMENTIA; DIBENZOTHIAZEPINES; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PSYCHOTIC DISORDERS; RESIDENCE CHARACTERISTICS; RISPERIDONE; SCHIZOPHRENIA; SEROTONIN ANTAGONISTS; UNITED STATES;

EID: 41149132872     PISSN: 03007995     EISSN: None     Source Type: Journal    
DOI: 10.1185/030079908X260989     Document Type: Article

References (36)

1. Khouzam HR, Battista MA, Emes R, Ahles S. Psychoses in late life: evaluation and management of disorders seen in primary care. Geriatrics 2005;60:26-33
2. Masand P. Clinical effectiveness of atypical antipsychotics in elderly patients with psychosis. Eur Neuropsychopharmacol 2004;14(Suppl 4):S461-S469
3. Hermann RC, Yang D, Ettner SL, et al. Prescription of antipsychotic drugs by office-based physicians in the United States, 1989-1997. Psychiatr Serv 2002;53:425-30
4. Aparasu RR, Bhatara V, Gupta S. US national trends in the use of antipsychotics during office visits,1998-2002. Ann Clin Psychiatry 2005;17:147-52
5. Rapoport M, Mamdani M, Shulman KI, et al. Antipsychotic use in the elderly: shifting trends and increasing costs. Int J Geriatr Psychiatry 2005;20:749-53
6. Schneider LS, Tariot PN, Dagerman KS, et al.; CATIE-AD Study Group. Effectiveness of atypical antipsychotic drugs in patients with Alzheimer's disease. New Engl J Med 2006;355:1525-38
7. Lieberman JA, Stroup TS, McEvoy JP, et al.; Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Investigators. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. New Engl J Med 2005;353:1209-23
8. Kuno E, Rothbard AB. Racial disparities in antipsychotic prescription patterns for patients with schizophrenia. Am J Psychiatry 2002;159:567-72
9. Kreyenbuhl J, Zito JM, Buchanan RW, et al. Racial disparity in the pharmacological management of schizophrenia. Schizophr Bull 2003;29:183-93
10. Opolka JL, Rascati KL, Brown CM, et al. Ethnic differences in use of antipsychotic medication among Texas Medicaid clients with schizophrenia. J Clin Psychiatry 2003;64:635-9
11. Luo RD, Belleti DA, Tran D, et al. National prescribing patterns in the management of extrapyramidal symptoms among patients with schizophrenia. Int J Psychiatry Med 2002;32:261-9
12. Herbeck DM, West JC, Ruditis I, et al. Variations in use of second-generation antipsychotic medication by race among adult psychiatric patients. Psychiatr Serv 2004;55:677-84
13. Copeland LA, Zeber JE, Valenstein M, Blow FC. Racial disparity in the use of atypical antipsychotic medications among veterans. Am J Psychiatry 2003;160:1817-22
14. Daumit GL, Crum RM, Guallar E, et al. Outpatient prescriptions for atypical antipsychotics for African Americans, Hispanics, and whites in the United States. Arch Gen Psychiatry 2003;60:121-8
15. Van Brunt DL, Gibson PJ, Ramsey JL, and Obenchain R. Outpatient use of major antipsychotic drugs in ambulatory care settings in the United States, 1997-2000. Med Gen Med 2003;5:16
16. Rochon PA, Stukel TA, Bronskill SE, et al. Variation in nursing home antipsychotic prescribing rates. Arch Intern Med 2007;167:676-83
17. Liperoti R, Mor V, Lapane KL, et al. The use of atypical antipsychotics in nursing homes. J Clin Psychiatry 2003;64:1106-12
18. Briesacher BA, Limcangco MR, Simoni-Wastila L, et al. The quality of antipsychotic drug prescribing in nursing homes. Arch Intern Med 2005;165:1280-5
19. Cohen SB. Sample design of the 1996 Medical Expenditure Panel Survey Household Component. Agency for Health Care Policy and Research, Rockville, MD. Available at: http://www.meps.ahrq.gov/data_files/publications/mr2/mr2.shtml [accessed September 23, 2007]
20. Medical Expenditure Panel Survey: Survey Background. Agency for Healthcare Research and Quality, Rockville, MD. Available at: http://www.meps.ahrq.gov/mepsweb/about_meps/survey_back.jsp [accessed September 23, 2007]
21. Medical Expenditure Panel Survey: Survey Questionnaires - Household Component. Agency for Healthcare Research and Quality, Rockville, MD. Available at: http://www.meps.ahrq.gov/mepsweb/survey_comp/survey.jsp [accessed September 23, 2007]
22. Moeller JF, Stagnitti MN, Horan E. Outpatient prescription drugs: data collection and editing in the 1996 Medical Expenditure Survey (HC-010A) Rockville (MD). Agency for Health Care Policy and Research; 2001. MEPS Methodology Report No. 12. AHRQ Pub. No. 01-0002
23. Machlin S, Yu W, Zodet M. Computing standard errors for MEPS estimates. January 2005. Agency for Healthcare Research and Quality, Rockville, MD. Available at: http://www.meps.ahrq.gov/mepsweb/survey_comp/standard_errors.jsp [accessed September 23, 2007]
24. MEPS Household Component Weighting & Estimation Issues Agency for Healthcare Research and Quality, Rockville, MD. Available at: http://www.meps.ahrq.gov/mepsweb/about_meps/workbook/WB-Weight_Estimat.pdf [accessed September 23, 2007]
25. Cerner Multum Lexicon Guide Available at http://www.multum.com/LexGuide. pdf [accessed September 23, 2007]
26. SAS 9.1. SAS Institute Inc, Cary, North Carolina
27. SUDAAN 7.5. Research Triangle Institute, Research Triangle Park, North Carolina
28. Andersen RM. A behavioral model of families' use of health services [Research Series 25]. Center for Health Administration Studies, University of Chicago: Chicago; 1968
29. Andersen RM. Revisiting the behavioral model and access to medical care: does it matter? J Health Soc Behav 1995;36:1-10
30. Bagnall AM, Jones L, Ginnelly L, et al. A systematic review of atypical antipsychotic drugs in schizophrenia. Health Technol Assess 2003;7:1-193
31. Deaths with antipsychotics in elderly patients with behavioral disturbances. FDA public health advisory. Available at: http://www.fda.gov/cder/ drug/advisory/antipsychotics.htm [accessed September 23, 2007]
32. Jin H, Meyer JM, Jeste DV. Atypical antipsychotics and glucose dysregulation: a systematic review. Schizophr Res 2004;71:195-212
33. Greenland S. An introduction to instrumental variables for epidemiologists. Int J Epidemiol 2000;29:722-9
34. Martens EP, Pestman WR, de Boer A, et al. Instrumental variables: application and limitations. Epidemiology 2006;17:260-7
35. Crown WH. Antidepressant selection and economic outcome: a review of methods and studies from clinical practice. Br J Psychiatry Suppl 2001;42:S18-S22
36. Chung S. Does the use of SSRIs reduce medical care utilization and expenditures? J Ment Health Policy Econ 2005;8:119-29